Cargando…

Identification and Validation of IFI44 as Key Biomarker in Lupus Nephritis

Lupus nephritis (LN) is a common and severe organ manifestation of systemic lupus erythematosus (SLE) and is a major cause of SLE related deaths. Early diagnosis is essential to improve the prognosis of patients with LN. To screen the potential biomarkers associated with LN, we downloaded the gene e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Lingling, Lan, Lan, Zhu, Tingting, Chen, Hongjun, Gu, Haifeng, Wang, Cuili, Chen, Ying, Wang, Minmin, Tu, Haiyan, Enghard, Philipp, Jiang, Hong, Chen, Jianghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574154/ https://www.ncbi.nlm.nih.gov/pubmed/34760904 http://dx.doi.org/10.3389/fmed.2021.762848

Ejemplares similares

Peripheral blood T-cell subset and its clinical significance in lupus nephritis patients
por: Wang, Huijing, et al.
Publicado: (2022)

Performance of the 2019 EULAR/ACR systemic lupus erythematosus classification criteria in a cohort of patients with biopsy-confirmed lupus nephritis
por: Wang, Huijing, et al.
Publicado: (2021)

Identification and Clinical Correlation Analysis of IFI44 in Systemic Lupus Erythematosus Combined with Bioinformatics and Immune Infiltration Analysis
por: Wang, Yuan, et al.
Publicado: (2023)

The Role of Hyaluronan and CD44 in the Pathogenesis of Lupus Nephritis
por: Yung, Susan, et al.
Publicado: (2012)

Characteristics and renal survival of patients with lupus nephritis with glomerular immunoglobulin G(4) deposition: a single-centre retrospective analysis
por: Jiang, Xue, et al.
Publicado: (2022)

Monocyte Chemotactic Protein-1, Fractalkine, and Receptor for Advanced Glycation End Products in Different Pathological Types of Lupus Nephritis and Their Value in Different Treatment Prognoses
por: Lan, Lan, et al.
Publicado: (2016)

IFI44L expression is regulated by IRF‐1 and HIV‐1
por: Li, Yutong, et al.
Publicado: (2020)

IFI44L as a Forward Regulator Enhancing Host Antituberculosis Responses
por: Jiang, Haiqin, et al.
Publicado: (2021)

The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkers
por: Kopetschke, Katharina, et al.
Publicado: (2015)

Epigenetic Regulation of IFI44L Expression in Monocytes Affects the Functions of Monocyte-Derived Dendritic Cells in Systemic Lupus Erythematosus
por: Luo, Shuaihantian, et al.
Publicado: (2022)

An Unusual and Rare Case of a Seronegative Male Patient With Lupus Nephritis
por: Chow, Jeff, et al.
Publicado: (2020)

RIPK3 Promotes JEV Replication in Neurons via Downregulation of IFI44L
por: Bian, Peiyu, et al.
Publicado: (2020)

Systematic identification of key extracellular proteins as the potential biomarkers in lupus nephritis
por: Zhou, Xue, et al.
Publicado: (2022)

Prioritization of Diagnostic and Prognostic Biomarkers for Lupus Nephritis Based on Integrated Bioinformatics Analyses
por: Chen, Zhimin, et al.
Publicado: (2021)

Difference of IFI44L methylation and serum IFN-a1 level among patients with discoid and systemic lupus erythematosus and healthy individuals
por: Zhang, Bo, et al.
Publicado: (2021)

Weighted gene co-expression network analysis identifies FCER1G as a key gene associated with diabetic kidney disease
por: Liu, Shanshan, et al.
Publicado: (2020)

Evidence for an IFN-inducible gene, Ifi202, in the susceptibility to systemic lupus
por: Rozzo, S, et al.
Publicado: (2003)

SDF4 Is a Prognostic Factor for 28-Days Mortality in Patients With Sepsis via Negatively Regulating ER Stress
por: Zhu, Tingting, et al.
Publicado: (2021)

IL-2 Therapy Diminishes Renal Inflammation and the Activity of Kidney-Infiltrating CD4+ T Cells in Murine Lupus Nephritis
por: Rose, Angelika, et al.
Publicado: (2019)

FAM89A and IFI44L for distinguishing between viral and bacterial infections in children with febrile illness
por: Tian, Shufeng, et al.
Publicado: (2021)

Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis
por: Bertolo, Martina, et al.
Publicado: (2020)

Novel Plasma Biomarker-Based Model for Predicting Acute Kidney Injury After Cardiac Surgery: A Case Control Study
por: Zhang, Yichi, et al.
Publicado: (2022)

Comprehensive Analysis of Immune Implication and Prognostic Value of IFI44L in Non-Small Cell Lung Cancer
por: Zeng, Yong, et al.
Publicado: (2022)

Metabolic profiling reveals new serum signatures to discriminate lupus nephritis from systemic lupus erythematosus
por: Zhang, Yamei, et al.
Publicado: (2022)

Transcriptomics analysis of sirolimus treatment in lupus nephritis
por: Wang, Dongdong, et al.
Publicado: (2019)

IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA
por: Zheng, Qingcong, et al.
Publicado: (2022)

IFI44L and C1QTNF5 as promising biomarkers of proliferative diabetic retinopathy
por: Shang, Mingxin, et al.
Publicado: (2022)

Revisited Cyclophosphamide in the Treatment of Lupus Nephritis
por: Quan, Xiao-ying, et al.
Publicado: (2022)

The Role of Autophagy in Lupus Nephritis
por: Wang, Linlin, et al.
Publicado: (2015)

ALW peptide ameliorates lupus nephritis in MRL/lpr mice
por: Wang, Huixia, et al.
Publicado: (2019)

Identification and characterization of antigen-specific CD4(+) T cells targeting renally expressed antigens in human lupus nephritis with two independent methods
por: Tesch, Sebastian, et al.
Publicado: (2020)

The Pathogenesis of Lupus Nephritis
por: Sterner, Rosalie M., et al.
Publicado: (2014)

Pediatric lupus nephritis
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2018)

Hyperhomocysteinemia and Lupus Nephritis
por: Timlin, Homa, et al.
Publicado: (2019)

Management of Lupus Nephritis
por: Tamirou, Farah, et al.
Publicado: (2021)

Lupus Nephritis and Dysbiosis
por: Monticolo, Marta, et al.
Publicado: (2023)

Gamma secretase dependent release of the CD44 cytoplasmic tail upregulates IFI16 in cd44(-/-) tumor cells, MEFs and macrophages
por: Schultz, Kristin, et al.
Publicado: (2018)

Lupus nephritis or not? A simple and clinically friendly machine learning pipeline to help diagnosis of lupus nephritis
por: Wang, Da-Cheng, et al.
Publicado: (2023)

Fetal and maternal outcome in patients with active lupus nephritis: comparison between new-onset and pre-existing lupus nephritis
por: Lian, Xing-Ji, et al.
Publicado: (2021)

The prognostic and clinical significance of IFI44L aberrant downregulation in patients with oral squamous cell carcinoma
por: Ou, Deming, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s00i2dmh5vuefm2vmg096qb0qn